The Bausch+Lomb IC-8 is a monofocal IOL that combines small aperture optics with the quality of an aspheric monofocal intraocular lens, offering a clear and continuous range of vision.
- ✅ EXTENDED DEPTH OF FOCUS, free from “blurry zones”(1)
- ✅ MONOFOCAL-LIKE BINOCULAR CONTRAST SENSITIVITY in bright and low light conditions
- ✅ RELIABLE RESULTS REGARDLESS OF ASTIGMATISM in eyes with as much as 1.50 D of corneal astigmatism (1;2)
📊 In a clinical trial, the IC-8™ IOL patients achieved comparable binocular distance at 6 months after surgery and superior intermediate and near vision to patients with bilateral monofocal IOLs (1).
📞 Contact a Medical DevEyes expert or visit our website to discover more results about this IOL Contactez un expert Medical DevEyes
- Food and Drug Administration. (2002). IC-8™ Apthera® Intraocular Lens (IOL) – P210005: FDA Summary of Safety and Effectiveness Data. Accessed May 7, 2023. https://www.accessdata.fda.gov/cdrh_docs/pdf21/P210005B.pdf.
- Burkhard Dick et al. Prospective multicenter trial of a small-aperture intraocular lens. Journal of Cataract and Refractive Surgery 2017: Vol. 43, Issue 7; 956-968.
